This report reviews the current state of the obesity market for both pharmaceuticals and medical devices, examining why the obesity market is of such importance across established and emerging economies and how current interventions measure up. In July 2011, the American Association of Clinical Endocrinologists (AACE) reclassified obesity as a diseased state, not a condition, in order to move it up the US healthcare agenda. In 2012, the FDA reviewed its stance on anti-obesity products and approved two new products that were previously declined. As it stands, there are over 40 medicines currently approved or used off label to treat …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=118080.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/advances-in-the-obesity-market-market-report.html.
No comments:
Post a Comment